Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/26/2026 | Q1 | $10.5B | -- | -- | $1.64 | -- |
| 12/04/2025 | Q4 | $9.9B | $20.9B | $1.31 | $1.43 | -$0.12 |
| 08/28/2025 | Q3 | $9.9B | $20.8B | $1.38 | $1.46 | -$0.08 |
| 05/22/2025 | Q2 | $9.6B | $25.6B | $4.42 | $1.28 | $3.14 |
| 02/27/2025 | Q1 | $9.3B | $21.1B | $1.09 | $1.39 | -$0.30 |
| 12/05/2024 | Q4 | $8.8B | $23B | $1.44 | $1.29 | $0.15 |
| 08/22/2024 | Q3 | $9.3B | $22.2B | -$0.10 | $1.52 | -$1.63 |
| 05/23/2024 | Q2 | $9.1B | $21.6B | $0.99 | $1.35 | -$0.36 |
| 02/29/2024 | Q1 | $9.2B | $21.6B | $1.14 | $1.43 | -$0.28 |
| 11/30/2023 | Q4 | -- | $20.8B | $1.09 | -- | -- |
| 08/24/2023 | Q3 | -- | $20B | $1.15 | -- | -- |
| 05/25/2023 | Q2 | -- | $18.1B | $1.25 | -- | -- |
| 03/02/2023 | Q1 | -- | $17.4B | $0.61 | -- | -- |
| 12/01/2022 | Q4 | -- | $17B | $2.72 | -- | -- |
| 08/25/2022 | Q3 | -- | $11.9B | $1.36 | -- | -- |
| 05/26/2022 | Q2 | -- | $10.2B | $1.63 | -- | -- |
| 03/03/2022 | Q1 | -- | $9.9B | $1.60 | -- | -- |
| 12/02/2021 | Q4 | -- | $9.6B | $1.62 | -- | -- |
| 08/26/2021 | Q3 | -- | $9.8B | $1.56 | -- | -- |
| 05/27/2021 | Q2 | -- | $9.2B | $1.58 | -- | -- |
| 02/25/2021 | Q1 | -- | $9.6B | $1.37 | -- | -- |
| 12/03/2020 | Q4 | -- | $10.3B | $2.12 | -- | -- |
| 08/27/2020 | Q3 | -- | $9.4B | $0.88 | -- | -- |
| 05/28/2020 | Q2 | -- | $9.9B | $0.58 | -- | -- |
| 02/27/2020 | Q1 | -- | $11.3B | $1.22 | -- | -- |
| 12/05/2019 | Q4 | -- | $11.1B | $1.16 | -- | -- |
| 08/29/2019 | Q3 | -- | $11.4B | $1.31 | -- | -- |
| 05/23/2019 | Q2 | -- | $11B | $1.28 | -- | -- |
| 02/28/2019 | Q1 | -- | $11B | $0.95 | -- | -- |
| 11/29/2018 | Q4 | -- | $11B | $1.21 | -- | -- |
| 08/30/2018 | Q3 | -- | $10.5B | $1.27 | -- | -- |
| 05/24/2018 | Q2 | -- | $10B | $1.21 | -- | -- |
| 03/01/2018 | Q1 | -- | $9.7B | $0.98 | -- | -- |
| 11/30/2017 | Q4 | -- | $9.5B | $1.14 | -- | -- |
| 08/31/2017 | Q3 | -- | $8.8B | $1.11 | -- | -- |
| 05/25/2017 | Q2 | -- | $7.9B | $0.98 | -- | -- |
| 03/02/2017 | Q1 | -- | $8.3B | $0.99 | -- | -- |
| 12/01/2016 | Q4 | -- | $8B | $0.92 | -- | -- |
| 08/25/2016 | Q3 | -- | $8B | $0.96 | -- | -- |
| 05/26/2016 | Q2 | -- | $7.5B | $0.81 | -- | -- |
| 02/25/2016 | Q1 | -- | $7.4B | $0.85 | -- | -- |
The Toronto-Dominion Bank reported $20.9B worth of top line sales in its most recent quarter.
The Toronto-Dominion Bank announced earnings per share of $1.31 which represents a miss of analyst forecast a $1.43 per share.
The Toronto-Dominion Bank reported -- that represents -- per share over the last quarter.
The Toronto-Dominion Bank's earnings are forecast to decrease from $8.25 per share to $5.82 per share next year representing a decrease of -20.33%.
The Toronto-Dominion Bank's next earnings date is February 26, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.